Status:
COMPLETED
Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China
Lead Sponsor:
Fudan University
Conditions:
Breast Neoplasm Female
Financial Toxicity
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The goal of this study is to access the impact of a financial navigation program on improving financial toxicity among patients with breast cancer in China. The main questions it aims to answer are: ...
Eligibility Criteria
Inclusion
- Newly diagnosed with breast cancer and undergoing surgery during this admission;
- Female, age 18 years or older;
- Receiving or expected to receive one or more of the following therapies: chemotherapy, radiotherapy, endocrine therapy, targeted therapy, and immunotherapy;
- Eastern Cooperative Oncology Group Performance Status 0-2;
- Provided informed consent to participate in this study.
Exclusion
- Diagnosed with ductal carcinoma in situ (DCIS)
- Presence of any serious psychiatric disorders;
- Cognitive impairments;
- Difficulty in reading, writing, or communicating in Chinese.
Key Trial Info
Start Date :
June 17 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 17 2024
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT06484140
Start Date
June 17 2024
End Date
November 17 2024
Last Update
February 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032